<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: Aberrant DNA methylation is common in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells </plain></SENT>
<SENT sid="1" pm="."><plain>Epigenetic alterations resulting in the loss of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppression gene functions are frequently involved in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> development and progression </plain></SENT>
<SENT sid="2" pm="."><plain>Recently, methylation of PCDH10 was reported to be associated with multiple <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancies</z:e> as well as some <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumors</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Whether the down-regulation of PCDH10 happens in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> remains unknown </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: Methylation status of PCDH10 was evaluated by methylation-specific PCR analysis </plain></SENT>
<SENT sid="5" pm="."><plain>The effects of PCDH10 re-expression were determined in growth, colony formation, cell cycle, and invasion assays </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: In this study, we found that 100 % (8 of 8) of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cell lines were silenced for PCDH10, but not <z:mpath ids='MPATH_458'>normal</z:mpath> colorectal epithelial cells </plain></SENT>
<SENT sid="7" pm="."><plain>Demethylation treatment confirmed that the reduced expression is associated closely with promoter methylation </plain></SENT>
<SENT sid="8" pm="."><plain>Hyper-methylation of PCDH10 was also detected in 85 % of primary <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumors</z:e>, but not in adjacent <z:mpath ids='MPATH_458'>normal</z:mpath> colorectal tissues </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Our results suggest that PCDH10 is an important <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppression gene with key roles of suppressing cell proliferation, clonogenicity, and inhibiting cell invasion in the development of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>Thus, PCDH10 methylation may constitute a useful biomarker of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients </plain></SENT>
</text></document>